Finasteride Tablet, Film Coated
Product Images NDC 50090-7086

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 50090-7086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteride-fig.1 (Finasteride Fig.1)

FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2)

Finasteride-fig.2 (Finasteride Fig.2)
This text shows comparison data between a Placebo Group and a Finasteride Group in a study. It includes the number of events, cumulative figures, the number at risk per year, and observation time in months. The data provides valuable insights for evaluating the effectiveness of finasteride treatment.*
FDA Label Image

Finasteride-fig.5 (Finasteride Fig.5)

FDA Label Image

Structutre (Finasteride Structure)

FDA Label Image

Finasteride-fig.3 (Finasteride Fig.3)

Finasteride-fig.3 (Finasteride Fig.3)
This information appears to be related to a study comparing the effects of Finasteride versus a placebo over a certain observation period in terms of the percentage of patients experiencing events. The data includes the number of events and patients at risk for each group during different months of observation. This data could be useful for evaluating the efficacy of Finasteride compared to a placebo in a clinical setting.*
FDA Label Image

Finasteride-fig4a (Finasteride Fig4a)

FDA Label Image

Label Image (Lbl500907086)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.